
Citius Pharmaceuticals CTXR
$ 0.69
0.06%
Quarterly report 2025-Q4
added 02-13-2026
Citius Pharmaceuticals PEG Ratio 2011-2026 | CTXR
Annual PEG Ratio Citius Pharmaceuticals
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.00125 | -0.000297 | 0.154 | 0.136 | -0.0527 | -0.0208 | -0.033 | -0.106 | 0.0629 | 1.9 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.9 | -0.106 | 0.204 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M | ||
|
AgeX Therapeutics
AGE
|
-0.51 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M | ||
|
Esperion Therapeutics
ESPR
|
0.799 | $ 3.13 | 0.55 % | $ 651 M | ||
|
Exelixis
EXEL
|
-2.14 | $ 48.2 | 8.51 % | $ 13.1 B | ||
|
Midatech Pharma plc
MTP
|
-0.0114 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | ||
|
Fortress Biotech
FBIO
|
0.044 | $ 2.53 | 2.85 % | $ 70.6 M | ||
|
Genfit SA
GNFT
|
-0.0281 | - | 2.54 % | $ 160 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | ||
|
Galapagos NV
GLPG
|
0.0003 | $ 28.81 | 1.48 % | $ 2.69 B | ||
|
Athira Pharma
ATHA
|
0.0276 | - | - | $ 269 M | ||
|
Genmab A/S
GMAB
|
0.277 | $ 27.95 | 1.5 % | $ 17.2 B | ||
|
Genprex
GNPX
|
-0.000095 | $ 0.91 | 2.24 % | $ 849 K | ||
|
Grifols, S.A.
GRFS
|
-0.077 | $ 8.4 | 1.63 % | $ 6.83 B | ||
|
InflaRx N.V.
IFRX
|
0.094 | $ 2.51 | 27.16 % | $ 152 M | ||
|
Ionis Pharmaceuticals
IONS
|
-0.108 | $ 77.0 | 2.33 % | $ 12.3 B | ||
|
BioNTech SE
BNTX
|
-12.8 | $ 94.64 | -0.9 % | $ 27.2 B | ||
|
Kamada Ltd.
KMDA
|
1.39 | $ 8.29 | 0.91 % | $ 260 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - | ||
|
Checkmate Pharmaceuticals
CMPI
|
0.189 | - | - | $ 231 M | ||
|
Kymera Therapeutics
KYMR
|
-0.532 | $ 85.79 | 3.72 % | $ 7.25 B | ||
|
Kazia Therapeutics Limited
KZIA
|
5.03 | $ 13.58 | 0.97 % | $ 1.8 B | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
-5.01 | $ 231.58 | -0.31 % | $ 4.24 B | ||
|
INmune Bio
INMB
|
-0.342 | $ 1.54 | - | $ 38.1 M | ||
|
Liquidia Corporation
LQDA
|
0.000305 | $ 41.64 | 3.75 % | $ 3.58 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
-0.144 | $ 22.58 | 1.03 % | $ 3.74 B | ||
|
Mirum Pharmaceuticals
MIRM
|
-0.428 | $ 107.36 | 1.46 % | $ 5.39 B | ||
|
MannKind Corporation
MNKD
|
2.51 | $ 3.61 | 26.17 % | $ 1.1 B | ||
|
Advaxis
ADXS
|
-0.000022 | - | -9.65 % | $ 45.9 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.000013 | $ 3.46 | -1.14 % | $ 5.7 M | ||
|
Aeterna Zentaris
AEZS
|
0.0493 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
4.05 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.00894 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
-0.000778 | - | 1.93 % | $ 17.4 M | ||
|
Akero Therapeutics
AKRO
|
-0.964 | - | - | $ 3.67 B | ||
|
Aptose Biosciences
APTO
|
-0.000164 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-0.0809 | - | -39.0 % | $ 4.57 M | ||
|
Akouos
AKUS
|
0.105 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
-2.41 | - | -0.23 % | $ 916 M | ||
|
Allakos
ALLK
|
0.664 | - | - | $ 28.6 M | ||
|
AlloVir
ALVR
|
0.1 | - | 4.14 % | $ 49.1 M | ||
|
Arcutis Biotherapeutics
ARQT
|
0.0316 | $ 24.0 | 2.46 % | $ 3.05 B | ||
|
Nanobiotix S.A.
NBTX
|
0.249 | $ 41.6 | 19.64 % | $ 286 B | ||
|
Allena Pharmaceuticals
ALNA
|
-0.0713 | - | 3.16 % | $ 1.9 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.000293 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
0.133 | - | - | $ 10.1 M | ||
|
Alpine Immune Sciences
ALPN
|
4.18 | - | - | $ 2.17 B |